نتایج جستجو برای: boost vaccination

تعداد نتایج: 84560  

Journal: :Infection and immunity 2004
Jose C Ferraz Evangelos Stavropoulos Min Yang Steve Coade Clara Espitia Douglas B Lowrie M Joseph Colston Ricardo E Tascon

Tuberculosis is responsible for >2 million deaths a year, and the number of new cases is rising worldwide. DNA vaccination combined with Mycobacterium bovis bacillus Calmette Guerin (BCG) represents a potential strategy for prevention of this disease. Here, we used a heterologous prime-boost immunization approach using a combination of DNA plasmids and BCG in order to improve the efficacy of va...

2012
Selma Tobudic Veronika Plunger Gere Sunder-Plassmann Markus Riegersperger Heinz Burgmann

UNLABELLED Renal transplant recipients are at increased risk of developing invasive pneumococcal diseases but may have poor response to the 23-valent pneumococcal polysaccharide vaccine (PPV). It may be possible to enhance immunogenicity by priming with 7-valent pneumococcal conjugate vaccine (7vPnC) and boosting with PPV 1 year later. In a randomized single-blind, controlled study, adult recip...

2003
JC Cerottini Daniel E. Speiser Donata Rimoldi Pascal Batard Danielle Liénard Ferdy Lejeune Jean-Charles Cerottini Pedro Romero

Tumor vaccines may induce activation and expansion of specific CD8 T cells which can subsequently destroy tumor cells in cancer patients. This phenomenon can be observed in approximately 5-20% of vaccinated melanoma patients. We searched for factors associated with T cell responsiveness to peptide vaccines. Peptide antigen-specific T cells were quantified and characterized ex vivo before and af...

Journal: :Vaccine 2008
Silvia I Cazorla Fernanda M Frank Pablo D Becker Ricardo S Corral Carlos A Guzmán Emilio L Malchiodi

Cruzipain (Cz), a key Trypanosoma cruzi enzyme, is a main candidate antigen for vaccines against Chagas' disease. We evaluated a vaccination protocol based on intradermal priming with recombinant Cz and intranasal boosting with rCz co-administered with a derivative of the TLR2/6 agonist MALP-2. Vaccination triggered strong systemic and mucosal antibody responses, and a vigorous cell-mediated im...

2018
Elisa Nemes Anneke C Hesseling Michele Tameris Katya Mauff Katrina Downing Humphrey Mulenga Penelope Rose Marieke van der Zalm Sharon Mbaba Danelle Van As Willem A Hanekom Gerhard Walzl Thomas J Scriba Helen McShane Mark Hatherill Charmaine Abrahams Deborah Abrahams Hadn Africa Veronica Baartman Beauty Bavuma Nicole Bilek Natasja Botes Yolande Brown Yolundi Cloete Margareth Damons Ronel De Vos Portia Dlakavu Karen Du Preez Mzwandile Erasmus Claudia Francis Hendrik Geldenhuys Mandy Geldenhuys Katriena Goedeman Sandra Golliath Angelique Hendricks Mouton Christiaan Hopley Ruwijda Jansen Carolynne Jones Alana Keyser Benjamin Kagina Gloria Khomba Fazlin Kola–Cassiem Sandra Kruger Daphne Leukes Loyiso Louw Angelique Luabeya Theresa Maart Lebohang Makhethe Simbarashe Mbabwe Eunice Mtshamba Boniswa Mvinjelwa Lungisa Nkantsu Julia Noble Sizwe Nqweniso Fajwa Opperman Christel Petersen Patiswa Plaatjie Susan Rossouw Roxanne Solomoms Marcia Steyn Liticia Swanepoel Asma Toefy Heidi van Deventer Elma van Rooyen Daphne van Ster Bongiwe Vazana Ashley Veldsman Noncedo Xoyana

Background Vaccination of human immunodeficiency virus (HIV)-infected infants with bacille Calmette-Guérin (BCG) is contraindicated. HIV-exposed newborns need a new tuberculosis vaccination strategy that protects against tuberculosis early in life and avoids the potential risk of BCG disease until after HIV infection has been excluded. Methods This double-blind, randomized, controlled trial c...

Journal: :Cellular & molecular immunology 2007
Yi Liu Lihui Xu Yiqun Jiang Jianfang Sun Xianhui He

The phenotype and function of antigen-specific CD8 T cells are closely associated with the efficacy of a therapeutic vaccination. Here we showed that multiple immunizations with LCMV gp33-41 peptide (KAV) in Freund's adjuvant could induce KAV-specific CD8 T cells with low expression of CD127 and CD62L molecules. The inhibitory receptor PD-1 was also expressed on a substantial part of KAV-specif...

2015
Giuseppe Lofano Arun Kumar Oretta Finco Giuseppe Del Giudice Sylvie Bertholet

Vaccination against influenza is the most effective way to protect the population. Current vaccines provide protection by stimulating functional B- and T-cell responses; however, they are poorly immunogenic in particular segments of the population and need to be reformulated almost every year due to the genetic instability of the virus. Next-generation influenza vaccines should be designed to i...

Journal: :Journal of immunology 2004
David Schrama Rong Xiang Andreas O Eggert Mads Hald Andersen Lars Østergaard Pedersen Ls Eckhart Kämpgen Ton N Schumacher Ralph R Reisfeld Jürgen C Becker

IL-2 has been approved for treatment of patients with cancer. Moreover, it has been used as a component of vaccines against cancer. In this regard, we have recently demonstrated that dendritic cell-based peptide vaccination in mice required IL-2 to mount an effective immune response against established melanoma metastases. In this study, we confirm this observation by use of tumor-targeted IL-2...

Journal: :Virology 2014
Matthew R Sandbulte Ratree Platt James A Roth Jamie N Henningson Kathleen A Gibson Daniela S Rajão Crystal L Loving Amy L Vincent

Live-attenuated influenza virus (LAIV) prime-boost vaccination previously conferred protection against heterologous H3N2 swine influenza challenge, including in piglets with maternally derived antibodies (MDA). Conversely, a whole-inactivated virus (WIV) vaccine was associated with enhanced disease. This study was aimed at identifying immune correlates of cross-protection. Piglets with and with...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید